There have been studies looking at anti estrogen and anti aromatase drugs for women with recurrence ovarian cancer. The drugs that have been used include
tamoxifen, arimidex, letrozole. The response rate has varied from 0 to 50 %..
there may be correlation with the hormone receptor status of your tumor but this has not been well studied. the side effects of these drugs are few - hot flashes, vaginal dryness, risk of blood clots, and more rarely prescription eye changes.